Reports Q1 revenue $392.9M, consensus $361.38M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS:
- Alkermes plc (ALKS) Q1 Earnings Cheat Sheet
- Alkermes: Positive Alixorexton Phase 2 Data in Narcolepsy Type 1 Support Advancement to Phase 3 and Reinforce Buy Rating
- Alkermes to present additional data from Vibrance-1 Phase 2 alixorexton study
- Alkermes announces publication of 56-week post hoc analysis of Lybalvi
- Alkermes price target raised to $36 from $34 at BofA